Physician profile
Gregory A Guell
NPI 1447460738
$2,633.88
in general payments reported to CMS, 2019-2025
24 companies · $399 in 2025
The $399 reported for 2025 was more than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $321 · 2020: $127 · 2021: $409 · 2022: $536 · 2023: $344 · 2024: $498 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,056 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,056.07 |
| Education | $184.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $478.98 | 2019-2023 | |
| Hologic Sales and Service, LLC | $388.65 | 2021-2025 | Myosure Tissue Removal Device, Novasure, Fluent Fluid Management System |
| Mayne Pharma Commercial LLC | $293.57 | 2023-2025 | |
| Astellas Pharma US INC | $247.59 | 2024-2025 | Veozah |
| Coopersurgical, INC. | $209.88 | 2019-2025 | Endosee, Paragard T 380a, Wallach Cryosurgical Equipment |
| Bayer Healthcare Pharmaceuticals INC. | $181.66 | 2019-2024 | |
| Medical Device Business Services, INC. | $119.11 | 2022 | |
| Pfizer INC. | $117.00 | 2022-2024 | |
| Biogen, INC. | $85.41 | 2025 | Zurzuvae |
| Intuitive Surgical, INC. | $73.46 | 2019 | |
| Millicent US INC | $70.74 | 2024-2025 | Intrarosa, Femlyv, Femring |
| Organon LLC | $68.79 | 2022-2024 | Nexplanon |
| Myovant Sciences INC. | $52.59 | 2022 | |
| Sumitomo Pharma America, INC. | $46.84 | 2023-2025 | Gemtesa, Myfembree |
| Avion Pharmaceuticals | $39.46 | 2020-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $32.97 | 2019 | |
| Ethicon US, LLC | $32.70 | 2020 | |
| Amag Pharmaceuticals, INC. | $28.59 | 2021 | |
| Allergan, INC. | $20.00 | 2019 | |
| Scynexis, INC. | $17.70 | 2022 | |
| Merck Sharp & Dohme LLC | $14.19 | 2019 | |
| Daiichi Sankyo INC. | $14.00 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Guell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.